Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer
Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer
复制标题
DOI:
10.21873/anticanres.14890
复制
发表时间:
2021-03
影响因子:
2
通讯作者:
Aya Tokuda;Toru Miyake;Daiki Yasukawa;Daiji Ikuta;K. Mukaisho;S. Murata;Tomoharu Shimizu;M. Tani
中科院分区:
文献类型:
--
作者:
Aya Tokuda;Toru Miyake;Daiki Yasukawa;Daiji Ikuta;K. Mukaisho;S. Murata;Tomoharu Shimizu;M. Tani
Background: Colonic cancer is associated with a low incidence of peritoneal metastasis compared with gastric cancer; however, the reason for this remains unclear. In this study, a model of peritoneal dissemination using the CT26 murine colon cancer cell line was used to analyze the physiological roles of cancer-derived exosomes. Materials and Methods: Exosomes were collected from the supernatant of CT26 cell culture by ultracentrifugation. The number of peritoneal disseminations in two mouse models of colonic cancer pre-administered exosomes or phosphate-buffered saline were compared. Results: Cancer-derived exosomes suppressed peritoneal dissemination compared to phosphate-buffered saline. After administration of exosomes, the number of intraperitoneal macrophages and the expression of inducible nitric oxide synthase increased. Furthermore, cancer-derived exosomes increased activated natural killer cells and interferon-γ expression. Conclusion: Tumor-derived exosomes from colonic cancer may suppress peritoneal metastasis via an immunological mechanism.